Tuesday, July 29, 2014

Praise for PharmGKB

›
PharmGKB is “the Holy Grail” for DNA STAT , a company that provides pharmacogenomics testing for patients. DNA STAT g...
Friday, July 25, 2014

Ifosfamide PK and PD pathways published in PG&G

›
Ifosfamide is a produg used in combination chemotherapy for the treatment of solid tumors. Around 20% of patients experience toxicity. Pathw...
Wednesday, July 16, 2014

New PharmGKB VIP Summary: CYP4F2

›
Cytochrome p450, family 2, subfamily F, polypeptide 2 (CYP4F2) is known to catalyze multiple biological reactions.  It is predominantly ex...
Monday, July 7, 2014

Introducing CFTR as a Very Important Pharmacogene (VIP)

›
Variants within the CFTR gene underlie Cystic Fibrosis (CF) . Traditionally, drugs used in the treatment of this disease have focused on a...
Tuesday, June 17, 2014

CPIC simvastatin & SLCO1B1 guideline 2014 update published

›
The 2014 update of CPIC guideline regarding SLCO1B1 and simvastatin-induced myopathy , has been published in Clinical Pharmacology and Thera...
Thursday, June 12, 2014

New publication: PharmGKB Uric acid-lowering drugs pathway

›
Disorders involving uric acid levels are prevalent (e.g. gout, hyperuricemia and resultant kidney failure) and pharmaceuticals that reduce t...
Saturday, June 7, 2014

Big Data Conference Videos

›
Videos of the talks at the Stanford Big Data Conference 2014 are now available to watch online ( view agenda ) . A selection of our favor...